Anti-CLA antibodies, human

Anti-CLA antibodies, human

Clone: REA1101 | Dilution: 1:50
Clone REA1101 recognizes the cutaneous lymphocyte-associated antigen (CLA), a specialized glycoform of P-selectin glycoprotein ligand-1 (PSGL-1). It serves as a ligand for selectins, including CD62E (ELAM-1) and CD62L (LECAM-1). CLA is a unique skin-homing receptor and is predominantly found on a minor subset of human T cells that infiltrate the skin. This post-translational modification of PSGL-1 is thought to serve as a mechanism to regulate tissue-specific homing of CD4
+
and CD8
+
memory/effector T cells from peripheral blood to the skin, which plays an essential role during many inflammatory and certain malignant skin diseases. In peripheral blood, CLA is not only found on skin-homing memory/effector T cells, but is also found to be expressed on memory/effector B cells, NK cells, blood dendritic cells, and on monocytes. CLA is furthermore found on Langerhans cells in the skin.
Additional information: Clone REA1101 displays negligible binding to Fc receptors.

Alternative Names

SELPLG, CD162, PSGL-1, PSGL1

Technical specifications

  • Antigen: CLA
  • Clone: REA1101
  • Isotype: recombinant human IgG1
  • Isotype control: REA Control (S) antibodies
  • Alternative names of antigen: SELPLG, CD162, PSGL-1, PSGL1
  • Entrez Gene ID: 6404
  • Molecular mass of antigen [kDa]: 39
  • Distribution of antigen: dendritic cells, Langerhans cells, monocytes, NK cells, T cells
  • Product format: Reagents are supplied in buffer containing stabilizer and 0.05% sodium azide.
  • Fixation: Cells should be stained prior to fixation, if formaldehyde is used as a fixative.
  • Storage: Store protected from light at 2–8 °C. Do not freeze.
  • Available conjugates: PE, APC, PerCP-Vio700
  • Selected References

    1. Santamaria Babi, L. F. et al. (1995) Migration of skin-homing T cells across cytokine-activated human endothelial cell layers involves interaction of the cutaneous lymphocyte-associated antigen (CLA), the very late antigen-4 (VLA-4), and the lymphocyte function-associated antigen-1 (LFA-1). J. Immunol. 154: 1543-1550
    2. Fuhlbrigge, R. C. et al. (1997) Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells. Nature 389: 978-981
    3. Yoshino, T. et al. (1999) Cutaneous lymphocyte antigen is expressed on memory/effector B cells in the peripheral blood and monocytoid B cells in the lymphoid tissues. Cell. Immunol. 197: 39-45
    4. Takahashi, R. et al. (2003)
      In vitro
      differentiation from naive to mature E-selectin binding CD4 T cells: acquisition of skin-homing properties occurs independently of cutaneous lymphocyte antigen expression.
      J. Immunol. 171: 5769-5777
    5. Bos, J. D. et al. (1993) Skin-homing T lymphocytes: detection of cutaneous lymphocyte-associated antigen (CLA) by HECA.452 in normal human skin. Arch. Dermatol. Res. 285(179): 179-183
Product options: 6
130-119-220

Anti-CLA-PE, human

for 30
tests
(1)
EUR 110,00 
130-119-043

Anti-CLA-PE, human

for 100
tests
(1)
EUR 265,00 
130-119-221

Anti-CLA-APC, human

for 30
tests
(1)
EUR 110,00 
130-119-044

Anti-CLA-APC, human

for 100
tests
(1)
EUR 265,00 
130-119-226

Anti-CLA-PerCP-Vio700, human

for 30
tests
(1)
EUR 120,00 
130-119-049

Anti-CLA-PerCP-Vio700, human

for 100
tests
(1)
EUR 290,00